|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.139
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.103
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.098
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.093
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.085
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.083
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.081
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.081
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.080
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.079
|
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
132 |
0.077
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.073
|
|
|
|
alcohol metabolic process
|
GO:0006066 |
116 |
0.072
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.072
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.071
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.069
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.065
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.063
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.062
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.061
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.059
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.059
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.055
|
|
|
|
steroid metabolic process
|
GO:0008202 |
119 |
0.054
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.053
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.053
|
|
|
|
vitamin d3 metabolic process
|
GO:0070640 |
3 |
0.053
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.052
|
|
|
|
cofactor metabolic process
|
GO:0051186 |
80 |
0.052
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.052
|
|
|
|
fatty acid metabolic process
|
GO:0006631 |
121 |
0.051
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.051
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.050
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.049
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.046
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.044
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.044
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.044
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.043
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.043
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.043
|
|
|
|
sulfur compound metabolic process
|
GO:0006790 |
100 |
0.042
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.042
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.042
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.042
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.041
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.041
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.041
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.041
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.041
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.040
|
|
|
|
response to nutrient levels
|
GO:0031667 |
109 |
0.040
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.039
|
|
|
|
cellular response to cadmium ion
|
GO:0071276 |
3 |
0.039
|
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.038
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.038
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.038
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.038
|
|
|
|
lipid localization
|
GO:0010876 |
126 |
0.037
|
|
|
|
regulation of protein maturation
|
GO:1903317 |
96 |
0.037
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.037
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.037
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.037
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.037
|
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.036
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.036
|
|
|
|
hormone secretion
|
GO:0046879 |
128 |
0.036
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.036
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.035
|
|
|
|
regulation of protein processing
|
GO:0070613 |
96 |
0.035
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.035
|
|
|
|
negative regulation of hydrolase activity
|
GO:0051346 |
71 |
0.034
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.034
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.034
|
|
|
|
cellular response to oxidative stress
|
GO:0034599 |
76 |
0.034
|
|
|
|
response to testosterone
|
GO:0033574 |
3 |
0.033
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.033
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.033
|
|
|
|
fat soluble vitamin biosynthetic process
|
GO:0042362 |
4 |
0.033
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.032
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.032
|
|
|
|
positive regulation of secretion by cell
|
GO:1903532 |
114 |
0.031
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.031
|
|
|
|
regulation of vasculature development
|
GO:1901342 |
88 |
0.031
|
|
|
|
activation of immune response
|
GO:0002253 |
138 |
0.031
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.031
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.031
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.031
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.031
|
|
|
|
cellular response to starvation
|
GO:0009267 |
57 |
0.030
|
|
|
|
regulation of blood pressure
|
GO:0008217 |
93 |
0.030
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.030
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.029
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.029
|
|
|
|
cellular response to molecule of bacterial origin
|
GO:0071219 |
83 |
0.029
|
|
|
|
response to oxidative stress
|
GO:0006979 |
123 |
0.029
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.029
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.029
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.029
|
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.029
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.029
|
|
|
|
secondary alcohol metabolic process
|
GO:1902652 |
3 |
0.029
|
|
|
|
cellular alcohol metabolic process
|
GO:0044107 |
3 |
0.028
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.028
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.028
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.028
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.027
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.027
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.027
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.027
|
|
|
|
nucleoside phosphate biosynthetic process
|
GO:1901293 |
79 |
0.027
|
|
|
|
cellular alcohol biosynthetic process
|
GO:0044108 |
3 |
0.027
|
|
|
|
mitochondrion organization
|
GO:0007005 |
134 |
0.026
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.026
|
|
|
|
calcitriol biosynthetic process from calciol
|
GO:0036378 |
3 |
0.026
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.026
|
|
|
|
organic acid biosynthetic process
|
GO:0016053 |
86 |
0.026
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.026
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.026
|
|
|
|
innate immune response
|
GO:0045087 |
157 |
0.026
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.026
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.026
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.026
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.026
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.026
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.025
|
|
|
|
response to reactive oxygen species
|
GO:0000302 |
56 |
0.025
|
|
|
|
positive regulation of cell adhesion
|
GO:0045785 |
80 |
0.025
|
|
|
|
negative regulation of protein processing
|
GO:0010955 |
79 |
0.025
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.025
|
|
|
|
vitamin d biosynthetic process
|
GO:0042368 |
3 |
0.025
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.025
|
|
|
|
cellular protein complex assembly
|
GO:0043623 |
116 |
0.024
|
|
|
|
adaptive immune response
|
GO:0002250 |
155 |
0.024
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.024
|
|
|
|
cellular response to extracellular stimulus
|
GO:0031668 |
81 |
0.024
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.024
|
|
|
|
negative regulation of vasculature development
|
GO:1901343 |
26 |
0.024
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.024
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.024
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.023
|
|
|
|
regulation of intracellular transport
|
GO:0032386 |
159 |
0.023
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.023
|
|
|
|
regulation of lipid metabolic process
|
GO:0019216 |
118 |
0.023
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.023
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.023
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.023
|
|
|
|
lymphocyte mediated immunity
|
GO:0002449 |
139 |
0.023
|
|
|
|
hormone metabolic process
|
GO:0042445 |
86 |
0.022
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.022
|
|
|
|
single organism cell adhesion
|
GO:0098602 |
156 |
0.022
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.022
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.022
|
|
|
|
response to radiation
|
GO:0009314 |
165 |
0.022
|
|
|
|
protein glycosylation
|
GO:0006486 |
55 |
0.022
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.022
|
|
|
|
glycoprotein metabolic process
|
GO:0009100 |
116 |
0.022
|
|
|
|
hexose metabolic process
|
GO:0019318 |
98 |
0.022
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.022
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.022
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.022
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.022
|
|
|
|
cell activation involved in immune response
|
GO:0002263 |
126 |
0.022
|
|
|
|
glycerolipid metabolic process
|
GO:0046486 |
122 |
0.021
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.021
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.021
|
|
|
|
regulation of cysteine type endopeptidase activity
|
GO:2000116 |
65 |
0.021
|
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
126 |
0.021
|
|
|
|
regulation of reactive oxygen species metabolic process
|
GO:2000377 |
40 |
0.021
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.021
|
|
|
|
cellular response to transforming growth factor beta stimulus
|
GO:0071560 |
88 |
0.021
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
207 |
0.021
|
|
|
|
carbohydrate homeostasis
|
GO:0033500 |
128 |
0.021
|
|
|
|
protein oligomerization
|
GO:0051259 |
67 |
0.021
|
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
122 |
0.021
|
|
|
|
lipid transport
|
GO:0006869 |
98 |
0.021
|
|
|
|
lipid catabolic process
|
GO:0016042 |
69 |
0.021
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.020
|
|
|
|
vascular process in circulatory system
|
GO:0003018 |
62 |
0.020
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.020
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.020
|
|
|
|
protein kinase b signaling
|
GO:0043491 |
74 |
0.020
|
|
|
|
reactive oxygen species biosynthetic process
|
GO:1903409 |
8 |
0.020
|
|
|
|
small molecule catabolic process
|
GO:0044282 |
71 |
0.020
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.020
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.020
|
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
114 |
0.020
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.020
|
Mouse |
|
|
angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure
|
GO:0001998 |
3 |
0.020
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.020
|
|
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
122 |
0.020
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.020
|
|
|
|
leukocyte mediated immunity
|
GO:0002443 |
174 |
0.020
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.020
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.019
|
|
|
|
fatty acid derivative metabolic process
|
GO:1901568 |
33 |
0.019
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.019
|
|
|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.019
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.019
|
|
|
|
regulation of cell substrate adhesion
|
GO:0010810 |
73 |
0.019
|
|
|
|
glucose homeostasis
|
GO:0042593 |
128 |
0.019
|
|
|
|
cellular response to lipopolysaccharide
|
GO:0071222 |
77 |
0.019
|
|
|
|
glycosylation
|
GO:0070085 |
62 |
0.019
|
|
|
|
cartilage development
|
GO:0051216 |
140 |
0.019
|
|
|
|
cellular response to peptide hormone stimulus
|
GO:0071375 |
92 |
0.019
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.019
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.019
|
|
|
|
organic hydroxy compound biosynthetic process
|
GO:1901617 |
77 |
0.019
|
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
174 |
0.019
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.019
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.019
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.019
|
|
|
|
glycoprotein biosynthetic process
|
GO:0009101 |
89 |
0.019
|
|
|
|
macromolecule glycosylation
|
GO:0043413 |
55 |
0.019
|
|
|
|
alcohol biosynthetic process
|
GO:0046165 |
43 |
0.019
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.019
|
|
|
|
muscle contraction
|
GO:0006936 |
101 |
0.018
|
|
|
|
fertilization
|
GO:0009566 |
127 |
0.018
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.018
|
|
|
|
positive regulation of secretion
|
GO:0051047 |
130 |
0.018
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.018
|
|
|
|
negative regulation of proteolysis
|
GO:0045861 |
74 |
0.018
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.018
|
|
|
|
female sex differentiation
|
GO:0046660 |
84 |
0.018
|
|
|
|
carboxylic acid biosynthetic process
|
GO:0046394 |
86 |
0.018
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.018
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.018
|
|
|
|
cellular response to inorganic substance
|
GO:0071241 |
37 |
0.018
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.018
|
|
|
|
cellular modified amino acid metabolic process
|
GO:0006575 |
63 |
0.018
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.018
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.018
|
|
|
|
regulation of endopeptidase activity
|
GO:0052548 |
89 |
0.018
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.018
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.018
|
|
|
|
cellular response to peptide
|
GO:1901653 |
92 |
0.018
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.018
|
|
|
|
regulation of inflammatory response
|
GO:0050727 |
147 |
0.018
|
|
|
|
response to peptide
|
GO:1901652 |
136 |
0.018
|
|
|
|
positive regulation of lipid metabolic process
|
GO:0045834 |
40 |
0.017
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.017
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.017
|
|
|
|
midgut development
|
GO:0007494 |
4 |
0.017
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.017
|
|
|
|
regulation of peptidase activity
|
GO:0052547 |
96 |
0.017
|
|
|
|
cellular response to external stimulus
|
GO:0071496 |
88 |
0.017
|
|
|
|
response to steroid hormone
|
GO:0048545 |
56 |
0.017
|
|
|
|
response to fibroblast growth factor
|
GO:0071774 |
47 |
0.017
|
|
|
|
regulation of neurotransmitter levels
|
GO:0001505 |
87 |
0.017
|
|
|
|
cellular response to insulin stimulus
|
GO:0032869 |
78 |
0.017
|
|
|
|
leukocyte mediated cytotoxicity
|
GO:0001909 |
62 |
0.017
|
|
|
|
regulation of hormone secretion
|
GO:0046883 |
88 |
0.017
|
|
|
|
cellular response to acid chemical
|
GO:0071229 |
68 |
0.017
|
|
|
|
leukocyte activation involved in immune response
|
GO:0002366 |
126 |
0.017
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.017
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.017
|
|
|
|
regulation of binding
|
GO:0051098 |
111 |
0.017
|
|
|
|
negative regulation of blood vessel morphogenesis
|
GO:2000181 |
25 |
0.017
|
|
|
|
negative regulation of peptidase activity
|
GO:0010466 |
46 |
0.017
|
|
|
|
glucose metabolic process
|
GO:0006006 |
92 |
0.017
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.017
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.017
|
|
|
|
response to insulin
|
GO:0032868 |
100 |
0.017
|
|
|
|
regulation of glucose metabolic process
|
GO:0010906 |
60 |
0.017
|
|
|
|
negative regulation of protein maturation
|
GO:1903318 |
79 |
0.016
|
|
|
|
regulation of systemic arterial blood pressure mediated by a chemical signal
|
GO:0003044 |
33 |
0.016
|
|
|
|
cellular response to biotic stimulus
|
GO:0071216 |
92 |
0.016
|
|
|
|
response to starvation
|
GO:0042594 |
65 |
0.016
|
|
|
|
monocarboxylic acid biosynthetic process
|
GO:0072330 |
61 |
0.016
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.016
|
|
|
|
granzyme mediated apoptotic signaling pathway
|
GO:0008626 |
1 |
0.016
|
|
|
|
t cell differentiation
|
GO:0030217 |
174 |
0.016
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.016
|
|
|
|
naphthalene containing compound metabolic process
|
GO:0090420 |
1 |
0.016
|
|
|
|
gonad development
|
GO:0008406 |
141 |
0.016
|
|
|
|
regulation of cellular response to growth factor stimulus
|
GO:0090287 |
82 |
0.016
|
|
|
|
negative regulation of hormone biosynthetic process
|
GO:0032353 |
4 |
0.016
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.016
|
|
|
|
endocrine process
|
GO:0050886 |
39 |
0.016
|
|
|
|
protein homooligomerization
|
GO:0051260 |
43 |
0.016
|
|
|
|
regulation of ketone biosynthetic process
|
GO:0010566 |
2 |
0.016
|
|
|
|
renal system process
|
GO:0003014 |
48 |
0.016
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.016
|
|
|
|
drug metabolic process
|
GO:0017144 |
4 |
0.016
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.016
|
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.016
|
|
|
|
carbohydrate biosynthetic process
|
GO:0016051 |
74 |
0.016
|
|
|
|
negative regulation of lipid metabolic process
|
GO:0045833 |
30 |
0.016
|
|
|
|
cellular amide metabolic process
|
GO:0043603 |
58 |
0.016
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.016
|
|
|
|
xenobiotic catabolic process
|
GO:0042178 |
1 |
0.016
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.016
|
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.016
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.016
|
|
|
|
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002460 |
145 |
0.015
|
|
|
|
benzene containing compound metabolic process
|
GO:0042537 |
5 |
0.015
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.015
|
Worm |
|
|
peptide transport
|
GO:0015833 |
133 |
0.015
|
|
|
|
spermatid differentiation
|
GO:0048515 |
115 |
0.015
|
|
|
|
cellular response to organic cyclic compound
|
GO:0071407 |
87 |
0.015
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.015
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.015
|
|
|
|
cellular response to nutrient levels
|
GO:0031669 |
64 |
0.015
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.015
|
|
|
|
icosanoid metabolic process
|
GO:0006690 |
33 |
0.015
|
|
|
|
positive regulation of defense response
|
GO:0031349 |
124 |
0.015
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.015
|
|
|
|
positive regulation of protein kinase b signaling
|
GO:0051897 |
32 |
0.015
|
|
|
|
regulation of carbohydrate metabolic process
|
GO:0006109 |
75 |
0.015
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.015
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.015
|
|
|
|
isoprenoid metabolic process
|
GO:0006720 |
29 |
0.015
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.015
|
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.015
|
|
|
|
sulfur compound biosynthetic process
|
GO:0044272 |
37 |
0.015
|
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
123 |
0.015
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.015
|
|
|
|
response to amino acid
|
GO:0043200 |
37 |
0.015
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.015
|
|
|
|
regulation of systemic arterial blood pressure
|
GO:0003073 |
61 |
0.015
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.015
|
|
|
|
response to nitrosative stress
|
GO:0051409 |
1 |
0.015
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.015
|
|
|
|
regulation of angiogenesis
|
GO:0045765 |
81 |
0.015
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.015
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.015
|
|
|
|
gluconeogenesis
|
GO:0006094 |
39 |
0.015
|
|
|
|
cellular biogenic amine metabolic process
|
GO:0006576 |
28 |
0.015
|
|
|
|
negative regulation of transferase activity
|
GO:0051348 |
85 |
0.015
|
|
|
|
regulation of angiotensin levels in blood
|
GO:0002002 |
4 |
0.015
|
|
|
|
c21 steroid hormone biosynthetic process
|
GO:0006700 |
3 |
0.015
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.015
|
|
|
|
regulation of cytoplasmic transport
|
GO:1903649 |
112 |
0.015
|
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
127 |
0.015
|
|
|
|
purine containing compound biosynthetic process
|
GO:0072522 |
70 |
0.014
|
|
|
|
terpenoid metabolic process
|
GO:0006721 |
25 |
0.014
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.014
|
|
|
|
renal tubular secretion
|
GO:0097254 |
2 |
0.014
|
|
|
|
regulation of nucleotide catabolic process
|
GO:0030811 |
122 |
0.014
|
|
|
|
monosaccharide metabolic process
|
GO:0005996 |
106 |
0.014
|
|
|
|
multi multicellular organism process
|
GO:0044706 |
109 |
0.014
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.014
|
|
|
|
sulfate assimilation
|
GO:0000103 |
3 |
0.014
|
|
|
|
regulation of actin filament based process
|
GO:0032970 |
99 |
0.014
|
|
|
|
ethanol metabolic process
|
GO:0006067 |
3 |
0.014
|
|
|
|
regulation of angiotensin metabolic process
|
GO:0060177 |
4 |
0.014
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.014
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.014
|
|
|
|
negative regulation of endopeptidase activity
|
GO:0010951 |
44 |
0.014
|
|
|
|
cell killing
|
GO:0001906 |
67 |
0.014
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.014
|
|
|
|
positive regulation of apoptotic signaling pathway
|
GO:2001235 |
95 |
0.014
|
|
|
|
regulation of lipid biosynthetic process
|
GO:0046890 |
54 |
0.014
|
|
|
|
response to peptide hormone
|
GO:0043434 |
127 |
0.014
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.014
|
|
|
|
purine nucleoside monophosphate metabolic process
|
GO:0009126 |
81 |
0.014
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.014
|
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.014
|
|
|
|
neutrophil mediated killing of gram positive bacterium
|
GO:0070946 |
2 |
0.014
|
|
|
|
olfactory learning
|
GO:0008355 |
2 |
0.014
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.014
|
|
|
|
peptidyl serine modification
|
GO:0018209 |
83 |
0.014
|
|
|
|
cellular lipid catabolic process
|
GO:0044242 |
52 |
0.014
|
|
|
|
diterpenoid metabolic process
|
GO:0016101 |
24 |
0.013
|
|
|
|
steroid biosynthetic process
|
GO:0006694 |
47 |
0.013
|
|
|
|
amide transport
|
GO:0042886 |
138 |
0.013
|
|
|
|
regulation of protein kinase b signaling
|
GO:0051896 |
56 |
0.013
|
|
|
|
purine nucleotide biosynthetic process
|
GO:0006164 |
65 |
0.013
|
|
|
|
nuclear division
|
GO:0000280 |
158 |
0.013
|
|
|
|
negative regulation of insulin secretion involved in cellular response to glucose stimulus
|
GO:0061179 |
4 |
0.013
|
|
|
|
negative regulation of angiogenesis
|
GO:0016525 |
25 |
0.013
|
|
|
|
regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090092 |
112 |
0.013
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.013
|
|
|
|
anion transport
|
GO:0006820 |
177 |
0.013
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.013
|
|
|
|
vasoconstriction
|
GO:0042310 |
27 |
0.013
|
|
|
|
regulation of cellular carbohydrate metabolic process
|
GO:0010675 |
75 |
0.013
|
|
|
|
sequestering of calcium ion
|
GO:0051208 |
18 |
0.013
|
|
|
|
negative regulation of hormone metabolic process
|
GO:0032351 |
4 |
0.013
|
|
|
|
establishment of blood nerve barrier
|
GO:0008065 |
3 |
0.013
|
|
|
|
regulation of steroid hormone biosynthetic process
|
GO:0090030 |
4 |
0.013
|
|
|
|
regulation of steroid metabolic process
|
GO:0019218 |
39 |
0.013
|
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
234 |
0.013
|
|
|
|
retinoic acid metabolic process
|
GO:0042573 |
12 |
0.013
|
|
|
|
negative regulation of growth
|
GO:0045926 |
99 |
0.013
|
|
|
|
negative regulation of defense response
|
GO:0031348 |
77 |
0.013
|
|
|
|
pyridine containing compound catabolic process
|
GO:0072526 |
4 |
0.013
|
|
|
|
purine ribonucleoside monophosphate metabolic process
|
GO:0009167 |
80 |
0.013
|
|
|
|
female gonad development
|
GO:0008585 |
71 |
0.013
|
|
|
|
reactive nitrogen species metabolic process
|
GO:2001057 |
0 |
0.013
|
|
|
|
positive regulation of cell substrate adhesion
|
GO:0010811 |
47 |
0.012
|
|
|
|
regulation of protein catabolic process
|
GO:0042176 |
108 |
0.012
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.012
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.012
|
|
|
|
meiotic cell cycle process
|
GO:1903046 |
77 |
0.012
|
|
|
|
sequestering of metal ion
|
GO:0051238 |
19 |
0.012
|
|
|
|
nucleoside monophosphate catabolic process
|
GO:0009125 |
59 |
0.012
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.012
|
|
|
|
dna recombination
|
GO:0006310 |
92 |
0.012
|
|
|
|
nucleocytoplasmic transport
|
GO:0006913 |
139 |
0.012
|
|
|
|
negative regulation of cellular response to growth factor stimulus
|
GO:0090288 |
46 |
0.012
|
|
|
|
positive regulation of immune effector process
|
GO:0002699 |
107 |
0.012
|
|
|
|
peptide metabolic process
|
GO:0006518 |
46 |
0.012
|
|
|
|
carboxylic acid transport
|
GO:0046942 |
100 |
0.012
|
|
|
|
actin filament organization
|
GO:0007015 |
113 |
0.012
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.012
|
|
|
|
response to alcohol
|
GO:0097305 |
48 |
0.012
|
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.012
|
|
|
|
mesangial cell differentiation
|
GO:0072007 |
4 |
0.012
|
|
|
|
leukocyte apoptotic process
|
GO:0071887 |
71 |
0.012
|
|
|
|
muscle cell development
|
GO:0055001 |
133 |
0.012
|
|
|
|
response to transforming growth factor beta
|
GO:0071559 |
88 |
0.012
|
|
|
|
cyclic nucleotide metabolic process
|
GO:0009187 |
59 |
0.012
|
|
|
|
lymphocyte activation involved in immune response
|
GO:0002285 |
93 |
0.012
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.012
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.012
|
|
|
|
dephosphorylation
|
GO:0016311 |
129 |
0.012
|
|
|
|
nuclear import
|
GO:0051170 |
95 |
0.012
|
|
|
|
insulin secretion
|
GO:0030073 |
89 |
0.012
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.012
|
|
|
|
positive regulation of fatty acid oxidation
|
GO:0046321 |
4 |
0.012
|
|
|
|
positive regulation of cell migration
|
GO:0030335 |
109 |
0.012
|
|
|
|
nucleoside monophosphate metabolic process
|
GO:0009123 |
85 |
0.012
|
|
|
|
muscle cell proliferation
|
GO:0033002 |
52 |
0.012
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.012
|
|
|
|
nicotinamide nucleotide metabolic process
|
GO:0046496 |
12 |
0.012
|
|
|
|
positive regulation of hormone secretion
|
GO:0046887 |
38 |
0.012
|
|
|
|
negative regulation of chemokine production
|
GO:0032682 |
4 |
0.012
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.012
|
|
|
|
ear development
|
GO:0043583 |
200 |
0.012
|
|
|
|
engulfment of apoptotic cell
|
GO:0043652 |
3 |
0.012
|
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
114 |
0.012
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.012
|
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.012
|
|
|
|
positive regulation of cell motility
|
GO:2000147 |
116 |
0.012
|
|
|
|
development of primary female sexual characteristics
|
GO:0046545 |
73 |
0.011
|
|
|
|
response to oxygen levels
|
GO:0070482 |
62 |
0.011
|
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
207 |
0.011
|
|
|
|
methylation
|
GO:0032259 |
134 |
0.011
|
|
|
|
positive regulation of camp mediated signaling
|
GO:0043950 |
3 |
0.011
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.011
|
|
|
|
progesterone metabolic process
|
GO:0042448 |
4 |
0.011
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.011
|
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.011
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.011
|
|
|
|
cell matrix adhesion
|
GO:0007160 |
68 |
0.011
|
|
|
|
acute inflammatory response
|
GO:0002526 |
41 |
0.011
|
|
|
|
nucleotide biosynthetic process
|
GO:0009165 |
78 |
0.011
|
|
|
|
negative regulation of multi organism process
|
GO:0043901 |
68 |
0.011
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.011
|
|
|
|
stem cell proliferation
|
GO:0072089 |
117 |
0.011
|
|
|
|
regulation of peptide transport
|
GO:0090087 |
91 |
0.011
|
|
|
|
production of molecular mediator of immune response
|
GO:0002440 |
103 |
0.011
|
|
|
|
rna processing
|
GO:0006396 |
105 |
0.011
|
|
|
|
naphthalene metabolic process
|
GO:0018931 |
1 |
0.011
|
|
|
|
cellular carbohydrate metabolic process
|
GO:0044262 |
119 |
0.011
|
|
|
|
single fertilization
|
GO:0007338 |
82 |
0.011
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.011
|
|
|
|
alpha beta t cell activation
|
GO:0046631 |
91 |
0.011
|
|
|
|
amino acid transmembrane transport
|
GO:0003333 |
37 |
0.011
|
|
|
|
positive regulation of reactive oxygen species metabolic process
|
GO:2000379 |
11 |
0.011
|
|
|
|
unsaturated fatty acid metabolic process
|
GO:0033559 |
31 |
0.011
|
|
|
|
positive regulation of growth
|
GO:0045927 |
104 |
0.011
|
|
|
|
response to phenylpropanoid
|
GO:0080184 |
22 |
0.011
|
|
|
|
tube formation
|
GO:0035148 |
140 |
0.011
|
|
|
|
mineralocorticoid biosynthetic process
|
GO:0006705 |
1 |
0.011
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.011
|
|
|
|
regulation of nucleocytoplasmic transport
|
GO:0046822 |
73 |
0.011
|
|
|
|
ribonucleotide biosynthetic process
|
GO:0009260 |
59 |
0.011
|
|
|
|
regulation of protein secretion
|
GO:0050708 |
82 |
0.011
|
|
|
|
myeloid cell homeostasis
|
GO:0002262 |
114 |
0.011
|
|
|
|
negative regulation of kinase activity
|
GO:0033673 |
81 |
0.011
|
|
|
|
regulation of innate immune response
|
GO:0045088 |
91 |
0.011
|
|
|
|
i kappab kinase nf kappab signaling
|
GO:0007249 |
85 |
0.011
|
|
|
|
inositol lipid mediated signaling
|
GO:0048017 |
41 |
0.011
|
|
|
|
negative regulation of homeostatic process
|
GO:0032845 |
71 |
0.011
|
|
|
|
atp catabolic process
|
GO:0006200 |
55 |
0.011
|
|
|
|
development of primary male sexual characteristics
|
GO:0046546 |
88 |
0.011
|
|
|
|
aldosterone metabolic process
|
GO:0032341 |
2 |
0.011
|
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.011
|
|
|
|
androgen biosynthetic process
|
GO:0006702 |
4 |
0.011
|
|
|
|
kidney epithelium development
|
GO:0072073 |
121 |
0.011
|
|
|
|
regulation of stem cell proliferation
|
GO:0072091 |
78 |
0.011
|
|
|
|
ribonucleoside monophosphate metabolic process
|
GO:0009161 |
80 |
0.011
|
|
|
|
phenol containing compound metabolic process
|
GO:0018958 |
60 |
0.011
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.011
|
|
|
|
fatty acid biosynthetic process
|
GO:0006633 |
41 |
0.011
|
|
